Cargando…

Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina

Retinitis pigmentosa (RP), an inherited retinal degenerative disease, is characterized by a progressive loss of rod photoreceptors followed by loss of cone photoreceptors. Previously, when tissue inhibitor of metalloproteinase 1 (TIMP1), a key extracellular matrix (ECM) regulator that binds to and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hwa Sun, Vargas, Andrew, Eom, Yun Sung, Li, Justin, Yamamoto, Kyra L., Craft, Cheryl Mae, Lee, Eun-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942829/
https://www.ncbi.nlm.nih.gov/pubmed/29742163
http://dx.doi.org/10.1371/journal.pone.0197322
_version_ 1783321526809919488
author Kim, Hwa Sun
Vargas, Andrew
Eom, Yun Sung
Li, Justin
Yamamoto, Kyra L.
Craft, Cheryl Mae
Lee, Eun-Jin
author_facet Kim, Hwa Sun
Vargas, Andrew
Eom, Yun Sung
Li, Justin
Yamamoto, Kyra L.
Craft, Cheryl Mae
Lee, Eun-Jin
author_sort Kim, Hwa Sun
collection PubMed
description Retinitis pigmentosa (RP), an inherited retinal degenerative disease, is characterized by a progressive loss of rod photoreceptors followed by loss of cone photoreceptors. Previously, when tissue inhibitor of metalloproteinase 1 (TIMP1), a key extracellular matrix (ECM) regulator that binds to and inhibits activation of Matrix metallopeptidase 9 (MMP9) was intravitreal injected into eyes of a transgenic rhodopsin rat model of RP, S334ter-line3, we discovered cone outer segments are partially protected. In parallel, we reported that a specific MMP9 and MMP2 inhibitor, SB-3CT, interferes with mechanisms leading to rod photoreceptor cell death in an MMP9 dependent manner. Here, we extend our initial rat studies to examine the potential of TIMP1 as a treatment in retinal degeneration by investigating neuroprotective effects in a classic mouse retinal degeneration model, rd(Pde6b-/-) (rd1). The results clearly demonstrate that intravitreal injections of TIMP1 produce extended protection to delay rod photoreceptor cell death. The mean total number of rods in whole-mount retinas was significantly greater in TIMP-treated rd1 retinas (postnatal (P) 30, P35 (P<0.0001) and P45 (P<0.05) than in saline-treated rd1 retinas. In contrast, SB-3CT did not delay rod cell death, leading us to further investigate alternative pathways that do not involve MMPs. In addition to inducing phosphorylated ERK1/2, TIMP1 significantly reduces BAX activity and delays attenuation of the outer nuclear layer (ONL). Physiological responses using scotopic electroretinograms (ERG) reveal b-wave amplitudes from TIMP1-treated retinas are significantly greater than from saline-treated rd1 retinas (P<0.05). In later degenerative stages of rd1 retinas, photopic b-wave amplitudes from TIMP1-treated rd1 retinas are significantly larger than from saline-treated rd1 retinas (P<0.05). Our findings demonstrate that TIMP1 delays photoreceptor cell death. Furthermore, this study provides new insights into how TIMP1 works in the mouse animal model of RP.
format Online
Article
Text
id pubmed-5942829
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-59428292018-05-18 Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina Kim, Hwa Sun Vargas, Andrew Eom, Yun Sung Li, Justin Yamamoto, Kyra L. Craft, Cheryl Mae Lee, Eun-Jin PLoS One Research Article Retinitis pigmentosa (RP), an inherited retinal degenerative disease, is characterized by a progressive loss of rod photoreceptors followed by loss of cone photoreceptors. Previously, when tissue inhibitor of metalloproteinase 1 (TIMP1), a key extracellular matrix (ECM) regulator that binds to and inhibits activation of Matrix metallopeptidase 9 (MMP9) was intravitreal injected into eyes of a transgenic rhodopsin rat model of RP, S334ter-line3, we discovered cone outer segments are partially protected. In parallel, we reported that a specific MMP9 and MMP2 inhibitor, SB-3CT, interferes with mechanisms leading to rod photoreceptor cell death in an MMP9 dependent manner. Here, we extend our initial rat studies to examine the potential of TIMP1 as a treatment in retinal degeneration by investigating neuroprotective effects in a classic mouse retinal degeneration model, rd(Pde6b-/-) (rd1). The results clearly demonstrate that intravitreal injections of TIMP1 produce extended protection to delay rod photoreceptor cell death. The mean total number of rods in whole-mount retinas was significantly greater in TIMP-treated rd1 retinas (postnatal (P) 30, P35 (P<0.0001) and P45 (P<0.05) than in saline-treated rd1 retinas. In contrast, SB-3CT did not delay rod cell death, leading us to further investigate alternative pathways that do not involve MMPs. In addition to inducing phosphorylated ERK1/2, TIMP1 significantly reduces BAX activity and delays attenuation of the outer nuclear layer (ONL). Physiological responses using scotopic electroretinograms (ERG) reveal b-wave amplitudes from TIMP1-treated retinas are significantly greater than from saline-treated rd1 retinas (P<0.05). In later degenerative stages of rd1 retinas, photopic b-wave amplitudes from TIMP1-treated rd1 retinas are significantly larger than from saline-treated rd1 retinas (P<0.05). Our findings demonstrate that TIMP1 delays photoreceptor cell death. Furthermore, this study provides new insights into how TIMP1 works in the mouse animal model of RP. Public Library of Science 2018-05-09 /pmc/articles/PMC5942829/ /pubmed/29742163 http://dx.doi.org/10.1371/journal.pone.0197322 Text en © 2018 Kim et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kim, Hwa Sun
Vargas, Andrew
Eom, Yun Sung
Li, Justin
Yamamoto, Kyra L.
Craft, Cheryl Mae
Lee, Eun-Jin
Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina
title Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina
title_full Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina
title_fullStr Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina
title_full_unstemmed Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina
title_short Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina
title_sort tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942829/
https://www.ncbi.nlm.nih.gov/pubmed/29742163
http://dx.doi.org/10.1371/journal.pone.0197322
work_keys_str_mv AT kimhwasun tissueinhibitorofmetalloproteinases1enhancesrodsurvivalintherd1mouseretina
AT vargasandrew tissueinhibitorofmetalloproteinases1enhancesrodsurvivalintherd1mouseretina
AT eomyunsung tissueinhibitorofmetalloproteinases1enhancesrodsurvivalintherd1mouseretina
AT lijustin tissueinhibitorofmetalloproteinases1enhancesrodsurvivalintherd1mouseretina
AT yamamotokyral tissueinhibitorofmetalloproteinases1enhancesrodsurvivalintherd1mouseretina
AT craftcherylmae tissueinhibitorofmetalloproteinases1enhancesrodsurvivalintherd1mouseretina
AT leeeunjin tissueinhibitorofmetalloproteinases1enhancesrodsurvivalintherd1mouseretina